Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease

被引:119
作者
McEnaney, Patrick J. [1 ]
Parker, Christopher G. [1 ]
Zhang, Andrew X. [1 ]
Spiegel, David A. [1 ,2 ]
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
关键词
RECEPTOR-TARGETED IMMUNOTHERAPY; PROTEIN-PROTEIN INTERACTIONS; LASTING ANTITUMOR IMMUNITY; GROWTH-FACTOR RECEPTOR; ALPHA-V INTEGRINS; FC-GAMMA-R; PLASMINOGEN-ACTIVATOR; MONOCLONAL-ANTIBODIES; BISPECIFIC ANTIBODIES; MULTIVALENT LIGANDS;
D O I
10.1021/cb300119g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic immunology, the development of synthetic systems capable of modulating and/or manipulating immunological functions, represents an emerging field of research with manifold possibilities. One focus of this area has been to create low molecular weight synthetic species, called antibody-recruiting molecules (ARMs), which are capable of enhancing antibody binding to disease-relevant cells or viruses, thus leading to their immune-mediated clearance. This article provides a thorough discussion of contributions in this area, beginning with the history of small-molecule-based technologies for modulating antibody recognition, followed by a systematic review of the various applications of ARM-based strategies. Thus, we describe ARMs capable of targeting cancer, bacteria, and viral pathogens, along with some of the scientific discoveries that have resulted from their development. Research in this area underscores the many exciting possibilities at the interface of organic chemistry and immunobiology and is positioned to advance both basic and clinical science in the years to come.
引用
收藏
页码:1139 / 1151
页数:13
相关论文
共 179 条
[101]   Redirecting circulating antibodies via ligand-hapten conjugates eliminates target cells in vivo [J].
Lussow, AR ;
Buelow, R ;
Fanget, L ;
Peretto, S ;
Gao, L ;
Pouletty, P .
JOURNAL OF IMMUNOTHERAPY, 1996, 19 (04) :257-265
[102]  
Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
[103]   Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C [J].
Margeridon-Thermet, Severine ;
Shafer, Robert W. .
VIRUSES-BASEL, 2010, 2 (12) :2696-2739
[104]  
Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1
[105]  
Meireles LMC, 2011, CURR TOP MED CHEM, V11, P248
[106]   Using bifunctional polymers presenting vancomycin and fluorescein groups to direct anti-fluorescein antibodies to self-assembled monolayers presenting D-alanine-D-alanine groups [J].
Metallo, SJ ;
Kane, RS ;
Holmlin, RE ;
Whitesides, GM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (15) :4534-4540
[107]   Induction of long-lasting antitumor immunity by concomitant cell therapy with allogeneic lymphocytes and trifunctional bispecific antibody [J].
Morecki, Shoshana ;
Lindhofer, Horst ;
Yacovlev, Elena ;
Gelfand, Yael ;
Ruf, Peter ;
Slavin, Shimon .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (08) :997-1003
[108]   Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation [J].
Morelli, Laura ;
Poletti, Laura ;
Lay, Luigi .
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2011, 2011 (29) :5723-5777
[109]   Bispecific antibodies for cancer immunotherapy: Current perspectives [J].
Müller D. ;
Kontermann R.E. .
BioDrugs, 2010, 24 (2) :89-98
[110]   Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate Cancer [J].
Murelli, Ryan P. ;
Zhang, Andrew X. ;
Michel, Julien ;
Jorgensen, William L. ;
Spiegel, David A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (47) :17090-+